Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1993 Sep;68(3):555–558. doi: 10.1038/bjc.1993.385

Long-term follow-up of pulmonary function in patients cured from testicular cancer with combination chemotherapy including bleomycin.

G Lehne 1, B Johansen 1, S D Fosså 1
PMCID: PMC1968399  PMID: 7688978

Abstract

A follow-up study of pulmonary function in two groups of patients with testicular cancer was performed 6-12 years after treatment. Both groups, 47 patients in each, had undergone retroperitoneal lymph node dissection (RPLND). Patients with pathological stage (ps) II had also received bleomycin (median 270 mg) and cisplatin (median 540 mg) in three or four courses which included vinblastine or etoposide. Patients in ps I and II were similar with respect to age, general health, observation period, inspired oxygen fraction (FiO2) and maximal arterial oxygen pressure (pO2) at RPLND, but four (8.2%) with psII disease developed densities on chest X-ray during chemotherapy. At the long-term follow-up the groups were similar with respect to physical exercise, smoking pattern, present drug treatment and history of cardiopulmonary disease. In both groups forced vital capacity (FVC), forced expiratory volume in one second (FEV1), and single breath transfer factor for carbon monoxide (TLCO) were within normal limits, and no difference was found between the groups. The combined data for both groups showed that smoking was highly associated with impairment in TLCO (P = 0.005), and smoking frequency was negatively correlated to TLCO (P = 0.002). We conclude that 3-4 courses with bleomycin, cisplatin and etoposide/vinblastine in testicular cancer patients do not lead to long-term impairment of pulmonary function.

Full text

PDF
555

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aass N., Fosså S. D., Ous S., Stenwig A. E., Lien H. H., Paus E., Kaalhus O. Prognosis in patients with metastatic non-seminomatous testicular cancer. Radiother Oncol. 1990 Apr;17(4):285–292. doi: 10.1016/0167-8140(90)90002-e. [DOI] [PubMed] [Google Scholar]
  2. BLAKEMORE W. S., FORSTER R. E., MORTON J. W., OGILVIE C. M. A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide. J Clin Invest. 1957 Jan;36(1 Pt 1):1–17. doi: 10.1172/JCI103402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Einhorn L. H., Donohue J. Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med. 1977 Sep;87(3):293–298. doi: 10.7326/0003-4819-87-3-293. [DOI] [PubMed] [Google Scholar]
  4. Einhorn L. H. Treatment strategies of testicular cancer in the United States. Int J Androl. 1987 Feb;10(1):399–405. doi: 10.1111/j.1365-2605.1987.tb00210.x. [DOI] [PubMed] [Google Scholar]
  5. Gietema J. A., Sleijfer D. T., Willemse P. H., Schraffordt Koops H., van Ittersum E., Verschuren W. M., Kromhout D., Sluiter W. J., Mulder N. H., de Vries E. G. Long-term follow-up of cardiovascular risk factors in patients given chemotherapy for disseminated nonseminomatous testicular cancer. Ann Intern Med. 1992 May 1;116(9):709–715. doi: 10.7326/0003-4819-116-9-709. [DOI] [PubMed] [Google Scholar]
  6. Goldiner P. L., Schweizer O. The hazards of anesthesia and surgery in bleomycin-treated patients. Semin Oncol. 1979 Mar;6(1):121–124. [PubMed] [Google Scholar]
  7. Hansen S. W., Groth S., Sørensen P. G., Rossing N., Rørth M. Enhanced pulmonary toxicity in smokers with germ-cell cancer treated with cis-platinum, vinblastine and bleomycin: a long-term follow-up. Eur J Cancer Clin Oncol. 1989 Apr;25(4):733–736. doi: 10.1016/0277-5379(89)90211-3. [DOI] [PubMed] [Google Scholar]
  8. LaMantia K. R., Glick J. H., Marshall B. E. Supplemental oxygen does not cause respiratory failure in bleomycin-treated surgical patients. Anesthesiology. 1984 Jan;60(1):65–67. doi: 10.1097/00000542-198401000-00014. [DOI] [PubMed] [Google Scholar]
  9. Lehne G., Lote K. Pulmonary toxicity of cytotoxic and immunosuppressive agents. A review. Acta Oncol. 1990;29(2):113–124. doi: 10.3109/02841869009126530. [DOI] [PubMed] [Google Scholar]
  10. Levi J. A., Thomson D., Sandeman T., Tattersall M., Raghavan D., Byrne M., Gill G., Harvey V., Burns I., Snyder R. A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-up. J Clin Oncol. 1988 Jul;6(7):1154–1160. doi: 10.1200/JCO.1988.6.7.1154. [DOI] [PubMed] [Google Scholar]
  11. Nichols C. R., Roth B. J., Williams S. D., Gill I., Muggia F. M., Stablein D. M., Weiss R. B., Einhorn L. H. No evidence of acute cardiovascular complications of chemotherapy for testicular cancer: an analysis of the Testicular Cancer Intergroup Study. J Clin Oncol. 1992 May;10(5):760–765. doi: 10.1200/JCO.1992.10.5.760. [DOI] [PubMed] [Google Scholar]
  12. Osanto S., Bukman A., Van Hoek F., Sterk P. J., De Laat J. A., Hermans J. Long-term effects of chemotherapy in patients with testicular cancer. J Clin Oncol. 1992 Apr;10(4):574–579. doi: 10.1200/JCO.1992.10.4.574. [DOI] [PubMed] [Google Scholar]
  13. Peckham M. J., McElwain T. J., Barrett A., Hendry W. F. Combined management of malignant teratoma of the testis. Lancet. 1979 Aug 11;2(8137):267–270. doi: 10.1016/s0140-6736(79)90288-5. [DOI] [PubMed] [Google Scholar]
  14. Peckham M. Testicular cancer. Acta Oncol. 1988;27(4):439–453. doi: 10.3109/02841868809093570. [DOI] [PubMed] [Google Scholar]
  15. Roth B. J., Greist A., Kubilis P. S., Williams S. D., Einhorn L. H. Cisplatin-based combination chemotherapy for disseminated germ cell tumors: long-term follow-up. J Clin Oncol. 1988 Aug;6(8):1239–1247. doi: 10.1200/JCO.1988.6.8.1239. [DOI] [PubMed] [Google Scholar]
  16. Sørensen P. G., Rossing N., Rørth M. Carbon monoxide diffusing capacity: a reliable indicator of bleomycin-induced pulmonary toxicity. Eur J Respir Dis. 1985 May;66(5):333–340. [PubMed] [Google Scholar]
  17. Van Barneveld P. W., Sleijfer D. T., van der Mark T. W., Mulder N. H., Koops H. S., Sluiter H. J., Peset R. Natural course of bleomycin-induced pneumonitis. A follow-up study. Am Rev Respir Dis. 1987 Jan;135(1):48–51. doi: 10.1164/arrd.1987.135.1.48. [DOI] [PubMed] [Google Scholar]
  18. van Barneveld P. W., Sleijfer D. T., van der Mark T. W., Mulder N. H., Donker A. J., Meijer S., Schraffordt Koops H., Sluiter H. J., Peset R. Influence of platinum-induced renal toxicity on bleomycin-induced pulmonary toxicity in patients with disseminated testicular carcinoma. Oncology. 1984;41(1):4–7. doi: 10.1159/000225781. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES